The present invention provides short activating RNA molecules which up regulate albumin production. The present invention also provides methods of up regulating albumin production such methods involving the use of short activating RNA molecules capable of increasing the expression of albumin. The present invention also provides the use of the short activating RNA molecules in therapy such as treating or preventing a hyperproliferative disorder and/or a disorder characterised by hypoalbuminemia.
